InnaVirVax Press Release on World AIDS Day
December 16, 2012
InnaVirVax: the Phase I/IIa clinical study of its VAC-3S immunotherapeutic vaccine in the treatment of HIV infection has achieved its primary endpoint InnaVirVax Press Release 30NOV2012
Blog
Selection of Recent Lectures by S Gharakhanian
September 28, 2012
Clinical Development in Chronic Viral Disease:Reflections and Experiences from Hepatitis C and HIV Infection. Lecture @ Division of Infectious Diseases, Brigham & Womans Hospital, Harvard Medical School, 30 July 2012 Valuable role of medical affairs in new drug approval and launch Medical Affairs Executive Forum, 12-13 April 2012, Morristown NJ. https://exlpharma.boxenterprise.net/medical...
Selection of Recent Publications
September 28, 2012
Gharakhanian S, Kotler DP. Diabetes mellitus, HIV infection, and vitamin D: time to act or time to think? AIDS 2011;25:531-3. Hézode Ch, Forestier N, Dusheiko G, Ferenci P, Pol S; Goeser T; Bronowicki J-P, Bourlière M, Gharakhanian S, Bengtsson L, McNair L, George S, Kieffer T, Kwong A, Kauffman R.S; Alam J, Pawlotsky J-M, Zeuzem S. Telaprevir and...